Joshua M Francis Selected Research

Joshua M Francis Research Topics

13	Neoplasms (Cancer) 01/2021 - 01/2009
3	Adenocarcinoma of Lung 01/2020 - 01/2013
2	Carcinogenesis 01/2018 - 11/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016 - 04/2015
2	Meningioma (Meningiomas) 06/2015 - 11/2014
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Adenocarcinoma 12/2020
1	Chordoma 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Glioma (Gliomas) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Oligodendroglioma 11/2016
1	Chromothripsis 06/2015
1	Hemangioblastoma 12/2014
1	Circulating Neoplastic Cells 05/2014
1	Lung Neoplasms (Lung Cancer) 11/2013

5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 12/2020 - 01/2013
3	ChromatinIBA 12/2020 - 01/2009
3	ErbB Receptors (EGF Receptor)IBA 03/2016 - 11/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2015
2	NAD (NADH)IBA 01/2021 - 01/2017
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2017
2	quinone (benzoquinone)IBA 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2017 - 11/2016
2	Phosphotransferases (Kinase)IBA 04/2015 - 11/2013
2	Cetuximab (Erbitux)FDA Link 04/2015 - 11/2013
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	Brachyury protein (Brachyury)IBA 01/2019
1	Factor V (Coagulation Factor V)IBA 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2018
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 11/2017
1	EnzymesIBA 01/2017
1	deoxynyboquinoneIBA 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2016
1	Complement System Proteins (Complement)IBA 05/2015
1	dacomitinibIBA 04/2015
1	AfatinibIBA 04/2015
1	Gefitinib (Iressa)FDA Link 04/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2015
1	Biomarkers (Surrogate Marker)IBA 11/2014
1	SolutionsIBA 05/2014
1	Monoclonal AntibodiesIBA 11/2013
1	Messenger RNA (mRNA)IBA 01/2009

6	Therapeutics 01/2021 - 04/2015
1	Radiotherapy 01/2021